CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Other events
- 4 Option exercise Chief Financial Officer acquired 39,000 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 156,000 shares (option exercise)
- 4 Open-market sale Director sold 6,500 shares at $4.75 ($30,875)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Director sold 6,500 shares at $5.25 ($34,125)
- 8-K Event Other events
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market sale Director sold 6,500 shares at $5.67 ($36,855)
- 8-K Event Other events
- 8-K Event Agreement ended · Exit or restructuring costs · Impairment
Page 19 of 44 · 872 filings